Mitchell & Pahl Private Wealth’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Mitchell & Pahl Private Wealth's PFE Position: Q4 2025 in Review
Mitchell & Pahl Private Wealth sold out of Pfizer (PFE) in Q4 2025, closing a stake of 8,097 shares — an estimated $206K sold.
Mitchell & Pahl Private Wealth first reported a position in PFE in Q4 2020 and held it in 20 quarters. The position peaked at $1.71M in Q4 2021. 2,915 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- Mitchell & Pahl Private Wealth reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
- Mitchell & Pahl Private Wealth sold 8,097 Pfizer shares in Q4 2025, an estimated $206K.
- Mitchell & Pahl Private Wealth first reported a position in Pfizer in Q4 2020 and held it in 20 quarters.
- Mitchell & Pahl Private Wealth's Pfizer position peaked at $1.71M in Q4 2021.
- 2,915 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on Mitchell & Pahl Private Wealth's 13F filing for Q4 2025, filed 14 Jan 2026.